Clinical Trial: GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Refractory Neuroblastoma
Study Type: INTERVENTIONAL
Official Title: Phase 1 Trial of GPC2-Directed Chimeric Antigen Receptor Autologous T Cells (GPC2 CAR T) for Relapsed or Refractory Neuroblastoma
Brief Summary:
This is a first in human dose escalation trial to determine the safety of administering GPC2 CAR T cells in patients with advanced neuroblastoma.
Read more